CIK 0001453593 · Non-accelerated filer<br>Smaller reporting company
Xtant Medical Holdings, Inc.
Sign in to watch- Ticker
- XTNT
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205313323
- Phone
- 406-388-0480
- Business address
- 664 CRUISER LANE, BELGRADE, MT, 59714
- Former names
- Bacterin International Holdings, Inc., K KITZ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-15 | Vizirgianakis Stavros G. Director | Grant or award · Stock Option (right to buy) | +42,345 | 42,345 | ||
| 2023-08-15 | MITCHELL-KELLER LORI D Director | Grant or award | +145,180 | 190,962 | ||
| 2023-08-15 | MITCHELL-KELLER LORI D Director | Grant or award · Stock Option (right to buy) | +28,230 | 28,230 | ||
| 2023-08-15 | McNamara Robert Director | Grant or award | +145,180 | 591,989 | ||
| 2023-08-15 | McNamara Robert Director | Grant or award · Stock Option (right to buy) | +28,230 | 28,230 | ||
| 2023-08-15 | Beeson Jonn R. Director | Grant or award | +145,180 | 197,229 | ||
| 2023-08-15 | Beeson Jonn R. Director | Grant or award · Stock Option (right to buy) | +28,230 | 28,230 | ||
| 2023-08-15 | BAKEWELL JOHN K Director | Grant or award | +145,180 | 593,726 | ||
| 2023-08-15 | BAKEWELL JOHN K Director | Grant or award · Stock Option (right to buy) | +28,230 | 28,230 | ||
| 2023-06-15 | MITCHELL-KELLER LORI D Director | Grant or award | +45,782 | 45,782 | ||
| 2023-05-15 | Beeson Jonn R. Director | Grant or award | +52,049 | 52,049 | ||
| 2023-02-15 | Schallenberger Mark A. Chief Operations Officer | Grant or award | +89,000 | 89,000 | ||
| 2023-02-15 | Schallenberger Mark A. Chief Operations Officer | Grant or award · Stock Option (right to buy) | +105,000 | 105,000 | ||
| 2023-01-18 | Neils Scott C Chief Financial Officer | Sale | −8,673 | $0.61 | $5K | 403,960 |
| 2022-11-15 | Vizirgianakis Stavros G. Director | Grant or award | +144,639 | 5,995,355 | ||
| 2022-10-19 | Browne Sean E President and CEO | Sale | −51,100 | $0.62 | $32K | 1,506,584 |
| 2022-10-18 | Browne Sean E President and CEO | Sale | −80,000 | $0.68 | $54K | 1,557,684 |
| 2022-10-07 | Vizirgianakis Stavros G. Director | Purchase | +2,264,861 | $0.48 | $1.1M | 5,850,716 |
| 2022-10-07 | Vizirgianakis Stavros G. Director | Purchase · Warrant | +566,214 | 566,214 | ||
| 2022-08-25 | Vizirgianakis Stavros G. Director | Grant or award | +70,776 | 3,585,855 |
Page 4 of 9 · 177 trades